chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Today we gave epinephrine to a patient and called 911. COVID-19 Vaccine Moderna 1st dose:  Lot # 030B21A  Called on radio at approximately 1:15pm from "elbow" in the road at the top of the lower parking lot outside of fenced area asking for clinical lead. Worker responded on radio. They said patient returning after receiving vaccine one hour ago and concerned she is having allergic reaction. Worker asked if patient needed 911 call and worker responded she was not sure. I grabbed the golf cart and the worker got our NP. I drove us to the corner. We arrived there 1:16pm.  Patient was in passenger seat of car. Spanish speaking only. Translation by myself and a family member. Patient reported receiving Moderna vaccine approximately 1 hour ago and now experiencing throat closing up and chest tightness. Her voice was very hoarse, almost a whisper. She appeared to have difficulty breathing. Noted use of accesory muscles and high respiratory rate. Breath sounds clear, no wheezing (checked by NP). She also reported history of allergic reactions and use of epinephrine pen.  I called 911 within first minute of arriving on scene. Also announced to city on radio that ambulance arriving to please clear traffic.  Epinephrine 0.3mg IM administered at approximately 1:20pm in right anterior lateral thigh by NP. Patient tolerated well. Reported feeling better within 1 min of Epinephrine administration. Visibly calmer. Respirations less labored and rate appeared within normal limits.  Ambulance arrived very shortly after epinephrine administration, in approximately 3 minutes. Patient was assisted to gurney and brought into ambulance. She was taken to the Hospital. The ambulance left at 1:28pm.
First Shingrix vaccine sore arm only.  Second 6 months later, severe flu-like symptoms including headache, muscle ache, nausea vomiting. Unable to hold anything down for 12+ hours so violent dry heaves.
Day. 6:  fever, headache , intense body aches more on the right side.  Vomited once but tensioned nauseous.  Day 7:  symptoms worsened . I had a fever throughout the night but fever broke my morning  Day 8 post vaccine, feeling much better, no fever.   I recognize these symptoms aren?t life threatening  and I could have been exposed to covid after the vaccine, I don?t know. I?m just trying to help get the data out there for the pharmaceutical companies and the public to have
2 days of fever, headache, body aches, chills, feeling tired, trouble sleeping; a lot of pain on my arm and swollen lymph nodes in armpit; on days 3 and 4 after vaccine, fever stopped, but I got severe headaches (migraine, nausea), diarrhea; on day 5, mild headache (but still had to take Tylenol to control it); on day 6, itchy, uncomfortable red rash, slightly burning feeling, on arm where vaccine was administered; still very sore arm. Lymph nodes on left side (armpit and neck) have been swollen since first day.
1/15, all day: very sore shoulder, brain fog, headache. Resolved by next day.  1/20 -1/23 all day: itchy skin around injection site on L shoulder.  1/18-present: lymph nodes in L axilla sore/swollen-- >Resolved in 1 day. Also I got a mysterious, firm lump under the skin on the anterior surface of my L shoulder (still there).   1/24 - present, all day: Visible, oval-shaped rash around injection site. Rash is 3 inches tall, 2 inches wide. Shoulder has vague soreness. Fingers on L hand have sensation of decreased bloodflow.
My son has Guillain-Barre. I was wondering if 4 doses of this medication had anything to do with it.
This case was reported by a nurse and described the occurrence of headache in a female pt in her thirties who received hep B vaccine recombinant (Engerix B) injection for prophylaxis. On 9/15/03 the pt received the 1st dose of Engerix B. On that date, she also received a tuberculin skin test. approximately four hrs post-immunization, on 9/15/03, the pt experienced headache, fatigue, fever and flu-like symptoms. The fatigue, fever and headache resolved the next day. The outcome of flu-like symptoms is unknown.
Headache, Myalgia, NauseaVomiting, tired, fatigue Narrative:
Low high blood pressure; fever; High bloosd pressre; Fell forward; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE ABNORMAL (Low high blood pressure), PYREXIA (fever), BLOOD PRESSURE INCREASED (High bloosd pressre) and FALL (Fell forward) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced FALL (Fell forward). On 04-Mar-2021, the patient experienced BLOOD PRESSURE ABNORMAL (Low high blood pressure), PYREXIA (fever) and BLOOD PRESSURE INCREASED (High bloosd pressre). At the time of the report, BLOOD PRESSURE ABNORMAL (Low high blood pressure), PYREXIA (fever), BLOOD PRESSURE INCREASED (High bloosd pressre) and FALL (Fell forward) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 212/101 (High) high, 199/91 (High) high, 192/92 (High) high, 140/68 (High) dropped in the middle of the day and 177/90 (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient called around 3pm to pharmacy saying that she's experiencing nausea- advised her to call 911 or go to emergency if it's really bad. Also told her to drink cola syrup or ginger tea to help with the nausea. She said it was bad enough for her to go to the emergency room or the doctor.
I did not have an adverse event after receiving the vaccine. I started feeling sick 01/17/2023 with sneezing, coughing and a slight fever. I tested positive for COVID-19 on 01/19/2023.  I had a telehealth visit with my doctor and got two prescriptions, doxycycline and prednisone, to help me my symptoms. I tolerated the medication without any complications.
About 20-25 minutes after receiving the vaccine, I began to notice some tingling of the lips which was followed by a similar tingling sensation  spreading across my face. The area surrounding my left eye had minor numbness following the tingling. Over the next t half hour, my face continues w an uncomfortable itchy/tingly/minor numbness feeling along with itchiness deep inside my right ear.  It subsided over the next hour or two. I did NOT experience any difficulties breathing or problems with my throat or tongue.
on 04/20/21 "Pt is a 44 year old male w/ hx of ADPKD s/p transplant, anemia, Hep B, Hep C, HTN, who presented to BHS-RO ED w/ complaints of cough. Tested COVID+" "Pt remained hemodynamic stable, on room air. Discharged home in stable condition." Discharged on 04/22/21.
rising temperature; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 27Mar2021 (Batch/Lot number: unknown) at the age of 62 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (DOSE 1, SINGLE (Batch/Lot No: ER8732)), administration date: 06Mar2021, when the patient was 62 years old, for COVID-19 immunisation. The following information was reported: BODY TEMPERATURE INCREASED (non-serious) with onset Mar2021, outcome "unknown", described as "rising temperature".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
24 hours after administration of vaccine resident became disoriented, tachycardic, diaphoretic, experienced shortness of breath. Transported to hospital 4/19/12 at 1330.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021 at 4:33 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Oct-2021 at 4:33 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 72.15 for dose administered on 27-Oct-2021.  No concomitant medications were reported. Batch number 035C21A underwent temperature excursion on 27-Oct-2021. The vials with temperature 29 - 35 degrees Fahrenheit which were moved to fridge on 29-Sept-2021 and beyond used date was 29-Oct-2021. 4 vials with temperature 32 degrees Fahrenheit at 10:00 AM which were moved to fridge on 05-Oct-2021 and beyond used date was 04-Nov-2021. Product moved to clinic on 27-Oct-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
chills; fatigue; swollen lymph nodes; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY), administration date 27Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (Dose 1), for Covid-19 immunization; Comirnaty (Dose 2), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 27Nov2021, outcome "unknown", described as "booster"; CHILLS (non-serious), outcome "unknown", described as "chills"; FATIGUE (non-serious), outcome "unknown", described as "fatigue"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swollen lymph nodes".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Breakthrough case admission after 2 vaccines MOderan 2/11/21 Lot# 037K20A;  Moderna 3/9/21 Lot# 027L20A
Patient states that last evening she developed red, raised bumps hives and rash on her neck and chest area.
Patient reported "dizziness", "room spinning", some nausea symptoms beginning 11 hours after administration of vaccine. Dizziness woke patient during the night due to severity. Symptoms were continuing at time of discussion with patient at approximately 56 hours after administration. Symptoms worsen with position change, movement.  Patient also reports striking top of head in a swimming pool approximately 4 hours after receiving vaccination.  Patient will see MD if symptoms do not improve.
This spontaneous report as received from a physician refers to a patient of unknown age. Physician reported that the patient was in the office now(30-JUL-2013) to receive dose 3 of GARDASIL (injection, lot#, dose/frequency, route and duration were unspecified) which would be late. Doses 1 and 2 (lot#, dose/frequency, route and duration were unspecified for both doses) were administered sometime in 2011 (unspecified dates). No symptoms reported. Outcome was not reported. Additional information has been requested.
Hive noted on 2/11/18 which spread to abdomen and thighs, off and on for about 7 days and resolved without any specific treatment.
pt recv vax & 6hr p/vax pt devel an inj site rxn characterized by erythema, edema & pruritus;pt recovered;this is 1 of 9 pt from this facility to devel an inj site rxn p/flu vax lot# 4978139
pt devel large welt @ inj site immed p/vax on 30OCT96; this was one of three cases reported by a RN;cross reference w/MFR report 0010150960041 & 0010150960043;
Sternum pain & right side chest pain  High fever of 100.2  Tingling of fingers  Dazed feeling
Pain in left axilla.Swelling in left axilla; Pain in left axilla.Swelling in left axilla; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Nov2021 17:00 (Lot number: FF2593) at the age of 51 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: OLMESARTAN.  The following information was reported: LYMPHADENOPATHY (non-serious), AXILLARY PAIN (non-serious) all with onset 17Nov2021 03:00, outcome "unknown" and all described as "Pain in left axilla. Swelling in left axilla". Therapeutic measures were not taken as a result of lymphadenopathy, axillary pain.  Additional information: Facility where the most recent COVID-19 vaccine was administered Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination Olmesartan. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No known allergies.  No follow-up attempts are possible. No further information is expected.
I had sore throat, cold, extreme fatigue, headache, running nose, loss sense of taste and smell. I tested positive for COVID-19 at home. I called me doctor and they gave me an infusion for COVID-19. In the summertime I started not feeling to well. When I saw my pulmonologist, he said my breathing was off. He did three different breathing test and he said that it was way lower than normal. He ordered a bronchoscopy and other procedures. They found a mucus plug in my lungs and black mold in my lungs. Eventually they found other problems and they referred me to a surgeon. I had another bronchoscopy to see if the medication they put me on cleared the mold. They did a hiatal hernia repair. They also found out I have an enlarged heart. I am having trouble now breathing. I also have a problem with my pancreas.
Swelling of ears eyes and face, wheezing, treated with Benadryl. Identical symptoms of peanut allergy from 1 month prior.
I passed out in my kitchen after feeling crummy all day. I was taking to the emergency room for low hemoglobin, I am being treated for low anemia. My hemoglobin is back up, but my anemia is low. I am currently seeing a hematologist and awaiting further testing to see if I need to go on iron supplements.
all over body itching without any rash when given the first dose.  Second dose the itching intensified
My arm because sore under my armpit on April 27, 2021 and by April 30,2021 my arm became very red and swollen in the arm that was injected. By May 7, 2021 the swelling and pain were gone.
Mother reported 6 hours of inconsolable crying, 1 day, post vax. She wasn't sure if it was due to shots or constipation.
RASH ON VARIOUS PARTS OF BODY, BACK, FINGERS, WRISTS ETC; ITCHING ON VARIOUS PARTS OF BODY, BACK, FINGERS, WRISTS ETC; This is a spontaneous report received from a contactable consumer, the patient. A 79-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via unspecified route of administration in the left arm on 08Mar2021 at 14:00 (at the age of 79-years-old), as a single dose for COVID-19 immunisation. The patient's medical history included chronic obstructive pulmonary disease, diabetes, asthma, arthritis etc (as reported) from unknown date to unknown date. Concomitant medications include metformin (MANUFACTURER UNKNOWN), glimepiride (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), unspecified medication "D and B", all from an unknown date for an unknown indication. Prior to vaccination, on an unspecified date, the patient was diagnosed with COVID-19. The patient was not tested positive for COVID-19, since having the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. The patient had allergy to Penicillin. On 09Mar2021, the patient experienced rash and itching on various parts of body, back, fingers, wrists etc. No therapeutic measures were taken for the reported events. The clinical outcome of the events rash and itching were not recovered.   No follow-up attempts are needed. No further information is expected.
Patient had slight swelling and redness. Was given  2.5mL of12.5mg/5mL of Benadryl P.O x1 in office. Lot: 1HK0857  EXP: 06/2023
Received MMR 7-12-13 7-21-13 mild rash, temp 99.5 ax 7-22-13 rash whole body and in mouth, temp 101.5 ax 7-23-13 saw dr at clinic.
SYMPTOMS: LIGHTHEADEDNESS (1:30PM), NAUSEA/DRY THROAT/WATER EYES (AROUND 2-230PM) BP: 140/76, THEN 124/84 @ 2:50PM. TREATMENT: EMS PROVIDED OXYGEN AT THE SITE AND TOOK HIM TO NEAREST HOSPITAL FOR MEDICAL EVAL.
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient given 1st dose of Pfizer covid-19 injection on August 17,2021 at 12pm.  While he was sitting in the waiting area for the 15minute observation period, he fainted,fell off chair.  We went to him, got him some water as he said he was thirsty.  He said it has happened before when he had a flu shot, but did not tell us this before so we could have him sit on floor.  He did bump his head when he fell from chair and we got him to lie down on his side. EMS checked him out, he was fine then left
This spontaneous case reported by a consumer, describes the occurrence of myalgia (soreness in her arm) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concurrent medical conditions included uterine cancer since Jul 24, 2021. Concomitant products included lenvima (lenvatinib mesylate) from Jul 24, 2021 to an unknown date for uterine cancer. On Aug 20, 2021, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19vaccine), unknown route; 1 dosage form. On an unknown date, received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Aug 20, 2021, patient experienced myalgia (soreness in her arm). At the time of the report, myalgia (soreness in her arm) outcome: unknown/not provided. Treatment information not provided for the adverse events. Reporter did not allow further contact.
Dizziness, Constipation, Extreme Fatigue, pain in arm form shot Narrative:  Significant impact on life as he missed work due to this
tiredness; muscle pain; chills; joint pain; fever 100 degree; feeling unwell; This is a spontaneous report from a contactable consumer (self-reported). A 34-years-old non pregnant female patient received bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection) via an unspecified route of administration in Arm Right on 10Feb2021 at 18:30 (Batch/Lot Number: EL0140) as single dose for covid-19 immunisation. Medical history included anxiety, depression, mild asthma and environmental allergies. Concomitant medication was not reported. Patient was not pregnant at the time of vaccination. Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient received list of any other medications the patient received within 2 weeks of vaccination. On 12Feb2021 at 19:30, the patient had experienced tiredness, muscle pain, chills, joint pain, fever 100 degree, feeling unwell. The patient was not diagnosed with COVID Prior to vaccination and the patient was not tested for COVID Since the vaccination. The outcome of the event was unknown.
A report was received from a health care professional on 10/20/2003 concerning a 49 year old female vaccinee who experienced redness and swelling on 10/13/2003 after receiving Fluvirin on the same day. The event was resolved at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Reference PJP -2003-00832, PJP-2003-00833, PJP-2003-00836
My heart rate doubled for 4 days after inj.  My physical therapist checked my pulse and found this to be true.  I had just had knee replacement surgery.  Felt like I was going to have a heart attack.  Have had occasional rapid heart beat.
Tingling in lips, requesting Benadryl. Vitals wnl. Benadryl PO given.
delirium; aches; chills; headache; fever; sore muscle in vaccine location; head congestion; earaches; brain fog; This is a spontaneous report from a non-contactable consumer reporting for herself   A 22-year-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8730) on 22Mar2021 at 10:00 am at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history included known allergy to sulfa. The patient received first dose of vaccine on 05Mar2021 (Lot #:EN6199) at 12:00 pm, on Left arm. Concomitant medications included ethinylestradiol, norgestimate (TRI FEMYNOR) and minocycline. On 22Mar2021 at 19:00 the patient experienced aches, chills, headache, fever, sore muscle in vaccine location, head congestion, earaches, brain fog and delirium. The patient recovered from the events on an unspecified date.    No follow-up attempts are possible. No further information is expected.